Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity
Source abstract
Abstract
Multifunctional nanoparticles are of significant importance for synergistic multimodal antitumor activity. Herein, zinc oxide (ZnO) was used as pH-sensitive nanoparticles for loading the chemotherapy agent doxorubicin (DOX) and the photosensitizer agent indocyanine green (ICG), and biocompatible low-molecular-weight heparin (LMHP) was used as the gatekeepers for synergistic photothermal therapy/photodynamic therapy/chemotherapy/immunotherapy. ZnO was decomposed into cytotoxic Zn2+ ions, leading to a tumor-specific release of ICG and DOX. ZnO simultaneously produced oxygen (O2) and reactive oxygen species (ROS) for photodynamic therapy (PDT). The released ICG under laser irradiation produced ROS for PDT and raised the tumor temperature for photothermal therapy (PTT). The released DOX directly caused tumor cell death for chemotherapy. Both DOX and ICG also induced immunogenic cell death (ICD) for immunotherapy. The in vivo and in vitro results presented a superior inhibition of tumor progression, metastasis and recurrence. Therefore, this study could provide an efficient approach for designing multifunctional nanoparticles for synergistic multimodal antitumor therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
Funding
National Natural Science Foundation of China · National Key Research and Development Program of China · Innovation Team of the Ministry of Education
References (73)
Show source-provided references
1. Advances in systemic therapies for triple negative breast cancer10.1136/bmj-2022-071674 ↗
2. Advances in immunotherapy for triple-negative breast cancer10.1186/s12943-023-01850-7 ↗
3. Deciphering breast cancer: From biology to the clinic10.1016/j.cell.2023.01.040 ↗
4. Diabetes mellitus in breast cancer survivors: Metabolic effects of endocrine therapy10.1038/s41574-023-00899-0 ↗
5. π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor10.1021/acsnano.3c06542 ↗
6. “Closed-Loop” O2-Economizer Induced In Situ Therapeutic Vaccine against Hypoxic Tumors10.1021/acsnano.3c05034 ↗
7. Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer10.1038/s41467-023-41389-1 ↗
8. All-in-One Engineering Multifunctional Nanoplatforms for Sensitizing Tumor Low-Temperature Photothermal Therapy In Vivo10.1021/acsnano.3c05991 ↗
9. Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced Phototherapy10.7150/thno.46076 ↗
10. Near-Infrared-II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis10.1002/advs.202206932 ↗
11. Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia10.1021/acs.chemrev.6b00525 ↗
12. Li, Z., Li, X., Lu, Y., Zhu, X., Zheng, W., Chen, K., Liu, S., Wu, J., and Guan, W. (2023). Improved Photodynamic Therapy Based on Glutaminase Blockage via Tumor Membrane Coated CB-839/IR-780 Nanoparticles. Small, e2305174.10.1002/smll.202305174 ↗
13. Controllable Star Cationic poly (Disulfide)s Achieve Genetically Cascade Catalytic Therapy by Delivering Bifunctional Fusion Plasmids10.1002/adma.202307190 ↗
14. Conquering the Hypoxia Limitation for Photodynamic Therapy10.1002/adma.202103978 ↗
15. Wang, X., Mao, Y., Sun, C., Zhao, Q., Gao, Y., and Wang, S. (2021). A versatile gas-generator promoting drug release and oxygen replenishment for amplifying photodynamic-chemotherapy synergetic anti-tumor effects. Biomaterials, 276.10.1016/j.biomaterials.2021.120985 ↗
16. Tumour microenvironment responsive nanoconstructs for cancer theranostic10.1016/j.nantod.2019.03.007 ↗
17. Sahu, A., Kwon, I., and Tae, G. (2020). Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia. Biomaterials, 228.10.1016/j.biomaterials.2019.119578 ↗
18. Huang, J., Huang, Y., Xue, Z., and Zeng, S. (2020). Tumor microenvironment responsive hollow mesoporous Co9S8@MnO2-ICG/DOX intelligent nanoplatform for synergistically enhanced tumor multimodal therapy. Biomaterials, 262.10.1016/j.biomaterials.2020.120346 ↗
19. Implanted, Wireless, Self-Powered Photodynamic Therapeutic Tablet Synergizes with Ferroptosis Inducer for Effective Cancer Treatment10.1002/advs.202302731 ↗
20. Intelligent Nanodelivery System-Generated 1O2 Mediates Tumor Vessel Normalization by Activating Endothelial TRPV4-eNOS Signaling10.1002/smll.202200038 ↗
21. Colloidal Approaches to Zinc Oxide Nanocrystals10.1021/acs.chemrev.2c00456 ↗
22. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo10.1002/smll.201903323 ↗
23. Liu, Y., Wang, Y., Zhen, W., Wang, Y., Zhang, S., Zhao, Y., Song, S., Wu, Z., and Zhang, H. (2020). Defect modified zinc oxide with augmenting sonodynamic reactive oxygen species generation. Biomaterials, 251.10.1016/j.biomaterials.2020.120075 ↗
24. DNA Nanoflower Eye Drops with Antibiotic-Resistant Gene Regulation Ability for MRSA Keratitis Target Treatment10.1002/smll.202304194 ↗
25. Doping Engineering to Modulate Lattice and Electronic Structure for Enhanced Piezocatalytic Therapy and Ferroptosis10.1002/adma.202304262 ↗
26. Functional Nucleic Acids-Engineered Bio-Barcode Nanoplatforms for Targeted Synergistic Therapy of Multidrug-Resistant Cancer10.1021/acsnano.3c02009 ↗
27. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death10.1038/s41467-019-11269-8 ↗
28. ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines10.1021/acsnano.2c01669 ↗
29. Tailoring Aggregation Extent of Photosensitizers to Boost Phototherapy Potency for Eliciting Systemic Antitumor Immunity10.1002/adma.202106390 ↗
30. A Photosensitizer Discretely Loaded Nanoaggregate with Robust Photodynamic Effect for Local Treatment Triggers Systemic Antitumor Responses10.1021/acsnano.1c10590 ↗
31. Zhao, P., Wang, M., Chen, M., Chen, Z., Peng, X., Zhou, F., Song, J., and Qu, J. (2020). Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials, 254.10.1016/j.biomaterials.2020.120142 ↗
32. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy10.1002/advs.202302119 ↗
33. A Sodium Alginate-Based Multifunctional Nanoplatform for Synergistic Chemo-Immunotherapy of Hepatocellular Carcinoma10.1002/adma.202301352 ↗
34. Li, D., Cao, Z., Chen, C., Li, H., He, S., Hou, X., Liang, M., Yang, X., and Wang, J. (2023). Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell-mediated anticancer immune response for cancer therapy. Biomaterials, 302.10.1016/j.biomaterials.2023.122339 ↗
35. Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy10.1021/acsnano.2c08240 ↗
36. Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death10.1002/anie.202310774 ↗
37. Metal-Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor-Targeting Peptides for Targeted Multimodal Cancer Therapy10.1002/advs.202302700 ↗
38. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity10.1038/s41467-023-39607-x ↗
39. Silane-Capped ZnO Nanoparticles for Use as the Electron Transport Layer in Inverted Organic Solar Cells10.1021/acsnano.8b01178 ↗
40. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel10.1016/j.biomaterials.2011.11.078 ↗
41. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity10.1016/j.jconrel.2015.12.006 ↗
42. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel10.1016/j.biomaterials.2012.10.029 ↗
43. A Metal-Free Mesoporous Carbon Dots/Silica Hybrid Type I Photosensitizer with Enzyme-Activity for Synergistic Treatment of Hypoxic Tumor10.1002/adfm.202300818 ↗
44. Enhanced photodynamic therapy/photothermo therapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system10.1016/j.ajps.2022.01.002 ↗
45. Molecular Engineering of High-Performance Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics Mediated by Acid-Triggered Nucleus-Targeted Nanovectors10.1021/acsnano.1c03700 ↗
46. Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex In Vitro and In Vivo10.1021/acs.molpharmaceut.2c00553 ↗
47. Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells10.1016/j.jconrel.2018.12.034 ↗
48. A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle10.1016/j.actbio.2021.09.052 ↗
49. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection10.1002/smll.201805182 ↗
50. Enhanced Primary Tumor Penetration Facilitates Nanoparticle Draining into Lymph Nodes after Systemic Injection for Tumor Metastasis Inhibition10.1021/acsnano.9b03472 ↗
51. Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy10.1002/adma.201706719 ↗
52. Monolayer Nanosheets with an Extremely High Drug Loading toward Controlled Delivery and Cancer Theranostics10.1002/adma.201707389 ↗
53. Controlled synthesis of a core-shell nanohybrid for effective multimodal image-guided combined photothermal/photodynamic therapy of tumors10.1038/s41427-019-0164-4 ↗
54. Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy10.1002/advs.202003679 ↗
55. Smart PdH@MnO2 Yolk-Shell Nanostructures for Spatiotemporally Synchronous Targeted Hydrogen Delivery and Oxygen-Elevated Phototherapy of Melanoma10.1021/acsnano.1c10450 ↗
56. Type I photodynamic therapy by organic-inorganic hybrid materials: From strategies to applications10.1016/j.ccr.2019.05.016 ↗
57. Marriage of Scintillator and Semiconductor for Synchronous Radiotherapy and Deep Photodynamic Therapy with Diminished Oxygen Dependence10.1002/anie.201408472 ↗
58. Overcoming the Achilles’ heel of photodynamic therapy10.1039/C6CS00616G ↗
59. Gene and Photothermal Combination Therapy: Principle, Materials, and Amplified Anticancer Intervention10.1002/smll.202307078 ↗
60. Multifunctional WS2@Poly(ethylene imine) Nanoplatforms for Imaging Guided Gene-Photothermal Synergistic Therapy of Cancer10.1002/adhm.201600633 ↗
61. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy10.1002/anie.201804882 ↗
62. Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy10.1002/adma.201902960 ↗
63. Inflammatory microenvironment remodelling by tumour cells after radiotherapy10.1038/s41568-020-0246-1 ↗
64. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses10.1039/C9CS00271E ↗
65. Enhancing cancer immunotherapy with nanomedicine10.1038/s41577-019-0269-6 ↗
66. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
67. Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors10.1038/s41467-020-19540-z ↗
68. Smart Injectable Hydrogels for Cancer Immunotherapy10.1002/adfm.201902785 ↗
69. Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention10.1021/acs.nanolett.2c00500 ↗
70. Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy10.1038/s41467-022-33891-9 ↗
71. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma10.1002/advs.202300637 ↗
72. Unified Therapeutic-Prophylactic Vaccine Demonstrated with a Postoperative Filler Gel to Prevent Tumor Recurrence and Metastasis10.1002/adfm.202206084 ↗
73. Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells10.1002/adfm.202201306 ↗